Overview

• The proposed site, reportedly nicknamed “TrumpRx,” is under discussion and has not been finalized, according to Bloomberg reporting cited by The Independent.
• Users would search for specific medicines and purchase them out of pocket at discounted rates directly from drugmakers, bypassing pharmacies, insurers and pharmacy benefit managers.
• The White House letters call for expanded direct-to-consumer options and price cuts in line with other developed nations, linking the concept to a broader pricing campaign.
• Some manufacturers already run or are testing direct channels, including Eli Lilly’s telehealth-based offers and a Pfizer–Bristol Myers Squibb platform for Eliquis, with Novo Nordisk and others exploring similar models.
• The administration’s pressure strategy has been reported to include pushing for global price parity and potential tariff threats for noncompliance, though key legal and operational details remain unresolved.